Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization (CDMO) has created the Pharmatek Foundation, a not-for-profit organization supporting volunteerism for causes in the San Diego community. The Foundation's ...
read more
Wednesday, August 08, 2012
Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today announced the appointment of Bruce Kutinsky as its Chief Operating Officer of its US operations effective September 1, 2012. Mr. Kutinsky was most recently the President of ...
read more
Boehringer Ingelheim announced today an agreement with Servier and its partner XOMA Corporation (Nasdaq: XOMA) to transfer XOMA’s technology and process for the commercial manufacture of gevokizumab, XOMA’s novel interleukin 1-beta (IL-1ß) allosteric...
read more
Cytovance® Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces Don Wuchterl as the new Senior Vice President of Manufacturing Operations
read more
Continuing to exceed industry expectations, CoreRx, a Tampa-based pharmaceutical development company, added two new critical roles to their growing organization; Director of Commercial Manufacturing, and a Manager of Marketing & Strategic Development...
read more
IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based pharmaceutical company, today announced that Jason Grenfell-Gardner has been appointed President and Chief Executive Officer of IGI Laboratories, Inc. effective July 30, 2012.
read more
Rentschler, a leading CMO for the development and production of biopharmaceuticals, has hosted its second Laupheimer Zelltage conference with the theme 'Bioprocess light' on June 11 and 12, 2012 in Laupheim, Germany. Over 190 leading scientists from ...
read more
Sandoz has completed its USD 1.525 billion acquisition of specialty US dermatology company Fougera Pharmaceuticals on a cash and debt free basis.
read more
Kabi, a leading provider of infusion therapy and clinical nutrition, and Fenwal Inc. a global leader specializing in separation technologies for blood and cell collection and therapy, announced today a definitive agreement for Fresenius Kabi to ...
read more
AMRI (NASDAQ: AMRI) announced today that its subsidiary, India Pvt. Ltd. has been recognized by Abbott Health Care Pvt. Ltd. for the reliable supply of generic medications for the period from April 2011 to March 2012. This is the second year in a row...
read more
Ricerca Biosciences, an integrated preclinical contract research organization (CRO) providing services to the biopharmaceutical industry, announces Dr. G. Lynn Miesel as the new technical director.
read more
Renaissance Acquisition Holdings, LLC (“Renaissance”), a portfolio company of RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has ...
read more
Almac is pleased to announce the launch of a mobile optimised version of its website, enabling biotech and pharma clients and prospective customers to access Almac’s content whilst out of the office with only a mobile to hand. The new mobile ready ...
read more
Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals and KAHR Medical Limited, that develops novel drugs based on the Signal Converter Proteins (SCP) technology for the treatment of cancer and ...
read more
Althea Technologies, a leading provider of development and manufacturing services for biopharmaceutical products, today announced that Dennis Fenton, Ph.D., will chair Althea’s Scientific Advisory Board and be appointed as Board Observer. Dr. Fenton ...
read more